• Our Solution
  • About
  • Team
  • Use Cases
    • Emergency Medicine
    • Out of Hospital
UltraSight
  • UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging

    UltraSight

    June 10, 2025
    Milestones, news

    UltraSight™ Secures KFDA Approval for AI-Driven Cardiac Imaging Software in South Korea SEOUL, SOUTH KOREA, June 9, 2025 — UltraSight™, a leader in digital health innovation, announced today that its real-time machine learning guidance software has received regulatory approval from South Korea’s Ministry of Food and Drug Safety (KFDA). The clearance, granted to UltraSight’s joint…

One Broadway, 14th Floor
Cambridge MA 02142

info@ultrasight.com

Contact Us

Contact Us Global

Section

Section

Customer check

UltraSight is committed to protecting and respecting your privacy, and we’ll only use and process your personal information to respond to your message and as described in our Privacy Policy.

Privacy policy *

Occasionally, we would like to contact you by email about our products and services, as well as other content that may be of interest to you. You may unsubscribe from such emails via the link provided in the emails. If you consent to receive such emails from us, please tick below:

Marketing contact
  • LinkedIn
  • Twitter

Regulatory Approvals and Labeling

Patents

User Manual

Support

Privacy Policy

Terms and Conditions

Technical Specifications

UltraSight is a proud partner of Next October in commemorating victims of the 2023 Hamas War.

Read about Alon Kleinnman’s memorial

Design: Anzelevich Code: E&R © All copyright reserved to UltraSight

UltraSight is thrilled to announce that we have received FDA clearance for UltraSight AI Guidance

Read the full press release